Preferred initial panel for the evaluation of lung inflammation or injury in various types of interstitial lung disease (ILD).
Quantitative Enzyme-Linked Immunosorbent Assay/ Quantitative Immunoturbidimetric
Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Transfer 3 mL serum to ARUP Standard Transport Tube. (Min: 1.5 mL)
Plasma, CSF, or other body fluids. Contaminated, heat-inactivated, hemolyzed, icteric, or severely lipemic specimens.
Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 month
Refer to report.
Compliance Statement D: For laboratory tests using a manufactured RUO kit. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
|Component Test Code*||Component Chart Name||LOINC|
|3001867||Krebs von den Lungen-6||93369-7|
|3001970||Human Surfactant Protein D||74541-4|
- Lung Injury Panel